Burning Rock Biotech Limited (BNR)
USD 2.79
(-2.79%)
USD 2.79
(-2.79%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -255.78 Million | -456.8 Million | -477.88 Million | -73.54 Million | -228.04 Million | -148.78 Million |
| Net Income | -653.68 Million | -971.23 Million | -796.69 Million | -407.23 Million | -169.15 Million | -177.49 Million |
| Depreciation & Amortization | 133.4 Million | 124.09 Million | 47.76 Million | 33.3 Million | 31.35 Million | 24.67 Million |
| Deferred income taxes | - | - | 15.39 Million | - | 15.61 Million | 1.36 Million |
| Stock-based compensation | 260.71 Million | 326.78 Million | 282.43 Million | 173.22 Million | 22.79 Million | 5.09 Million |
| Change in working capital | -52.15 Million | 6.32 Million | -62.39 Million | 112.09 Million | -130.46 Million | -6.16 Million |
| Other non-cash items | 35.18 Million | 57.21 Million | 35.61 Million | 15.06 Million | 1.81 Million | 3.73 Million |
| Investing Cash Flow | -9.3 Million | -7.46 Million | 81.69 Million | -109.31 Million | -346.66 Million | 106.09 Million |
| Investments in PPE | -9.38 Million | -62.03 Million | -213.44 Million | -79.53 Million | -45.73 Million | -24.71 Million |
| Acquisitions | - | - | 2.52 Million | 3.96 Million | 401 Thousand | - |
| Investment purchases | - | - | -63.92 Million | -348.42 Million | -408.62 Million | - |
| Sales/Maturities of investments | - | 65.59 Million | 358.5 Million | 318 Million | 107.6 Million | 130.68 Million |
| Other Investing Activities | -9.3 Million | -11.03 Million | -1.96 Million | -3.31 Million | -303 Thousand | 122 Thousand |
| Financing Cash Flow | -48.83 Million | -86.23 Million | -52.89 Million | 2.16 Billion | 571.73 Million | 83.39 Million |
| Debt repayment | - | -2.37 Million | -44.8 Million | -43.8 Million | -96.31 Million | -13.71 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -6.97 Million | -71.83 Million | -4.27 Million | -3.5 Million | -4.15 Million | -1.5 Million |
| Common Stock Issuance | - | - | - | 1.85 Billion | - | - |
| Other Financing Activities | -48.83 Million | -12.03 Million | -3.82 Million | 721.58 Million | 672.21 Million | 98.6 Million |
| Accounts receivables | -12.38 Million | -21.5 Million | -18.93 Million | -13.04 Million | -65.94 Million | 4.16 Million |
| Accounts payables | -31.12 Million | 16.63 Million | -5.1 Million | 25.84 Million | -3.32 Million | 2.2 Million |
| Inventory | 57.27 Million | 11.2 Million | -66.99 Million | -9.44 Million | -8.12 Million | -32.25 Million |
| Other working capital | -17.27 Million | -6.32 Million | 28.63 Million | 108.74 Million | -53.07 Million | 19.72 Million |
| Cash at beginning of period | 925.26 Million | 1.43 Billion | 1.92 Billion | 98.24 Million | 95.33 Million | 54.78 Million |
| Cash at end of period | 615.21 Million | 925.26 Million | 1.43 Billion | 1.92 Billion | 98.24 Million | 95.33 Million |
| Capital Expenditure | -9.38 Million | -62.03 Million | -213.44 Million | -79.53 Million | -45.73 Million | -24.71 Million |
| Effect of forex changes on cash | 3.86 Million | 36.66 Million | -37 Million | -155.9 Million | 5.87 Million | -159 Thousand |
| Net cash flow / Change in cash | -310.05 Million | -513.84 Million | -486.09 Million | 1.82 Billion | 2.91 Million | 40.54 Million |
| Free Cash Flow | -265.16 Million | -518.83 Million | -691.33 Million | -153.08 Million | -273.77 Million | -173.49 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | -121.54 Million | -162.21 Million | -653.68 Million | -174.98 Million | -131.24 Million |
| Depreciation & Amortization | - | - | 131.45 Million | 133.4 Million | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 69.38 Million | 71.34 Million | 260.71 Million | 73.39 Million | 37.81 Million |
| Change in working capital | - | - | -4.36 Million | -52.15 Million | - | - |
| Other non-cash items | -40.83 Million | 11.95 Million | 74.85 Million | 35.18 Million | 54.17 Million | 14.21 Million |
| Investing Cash Flow | -227 Thousand | -2.38 Million | -328 Thousand | -9.3 Million | -1.98 Million | -2.92 Million |
| Investments in PPE | - | - | -8.1 Million | -9.38 Million | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -227 Thousand | -2.38 Million | -328 Thousand | -9.3 Million | -1.98 Million | -2.92 Million |
| Financing Cash Flow | - | - | -1.9 Million | -48.83 Million | -45.88 Million | -1 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -6.97 Million | -6.97 Million | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | -1.9 Million | -48.83 Million | -45.88 Million | -1 Million |
| Accounts receivables | - | - | -16.39 Million | -12.38 Million | - | - |
| Accounts payables | - | - | - | -31.12 Million | - | - |
| Inventory | - | - | 57.27 Million | 57.27 Million | - | - |
| Other working capital | - | - | -45.24 Million | -17.27 Million | - | - |
| Cash at beginning of period | 572.67 Million | 615.21 Million | 636.74 Million | 925.26 Million | 733.27 Million | 803.14 Million |
| Cash at end of period | 533.04 Million | 572.67 Million | 615.21 Million | 615.21 Million | 636.74 Million | 733.27 Million |
| Capital Expenditure | - | - | -8.1 Million | -9.38 Million | - | - |
| Effect of forex changes on cash | 1.43 Million | 53 Thousand | -3.27 Million | 3.86 Million | -1.23 Million | 13.27 Million |
| Net cash flow / Change in cash | -39.62 Million | -42.54 Million | -21.53 Million | -310.05 Million | -96.52 Million | -69.86 Million |
| Free Cash Flow | -40.83 Million | -40.2 Million | -24.12 Million | -265.16 Million | -47.41 Million | -79.2 Million |
BRKN
601211
EIX
KRN
EXM
2282